WILYY (Demant AS) Gross-Profit-to-Asset % : 52.22% (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Demant AS Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Demant AS's annualized Gross Profit for the quarter that ended in Dec. 2024 was $2,409 Mil. Demant AS's average Total Assets over the quarter that ended in Dec. 2024 was $4,614 Mil. Therefore, Demant AS's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 52.22%.

Demant AS Gross-Profit-to-Asset % Historical Data

The historical data trend for Demant AS's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS Gross-Profit-to-Asset % Chart

Demant AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

48.82

55.55

52.03

54.76

53.17

Demant AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															53.12	54.31	55.15	53.71	52.22

Competitive Comparison of Demant AS's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Demant AS's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Demant AS's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Demant AS's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Demant AS Gross-Profit-to-Asset % Calculation

Demant AS's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2024 )	/	( (Total Assets (A: Dec. 2023 )	+	Total Assets (A: Dec. 2024 ))	/ count )
	=	2399.573	/	( (4469.187	+	4556.24)	/ 2 )
	=	2399.573	/	4512.7135
	=	53.17 %

Demant AS's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	2409.402	/	( (4671.455	+	4556.24)	/ 2 )
	=	2409.402	/	4613.8475
	=	52.22 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Demant AS Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Demant AS's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Demant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILYY) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

WILLF:USA DEMANc:UK 0RGT:UK DEMANT:Denmark WDH1:Germany DEMA:Austria

Address

Kongebakken 9, Smorum, DNK, 2765

Website

https://www.demant.com

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.